as on December 3, 2025 at 1:45 am IST
Day's Low
Day's High
5.15%
Downside
1.98%
Upside
52 Week's Low
52 Week's High
48.91%
Downside
4.95%
Upside
Check Sophia Genetics Sa market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$333.8M
EPS (TTM)
-1.04
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-68.6M
Revenue (TTM)
73.3M
Profit Margin
-102.29%
Return On Equity TTM
-86.09%
Compare market cap, revenue, PE, and other key metrics of Sophia Genetics Sa with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $333.8M | NA | NA | -102.29% | |
| BUY | $9.1B | 43.53% | 63.75 | 11.49% | |
| HOLD | $9.7B | NA | 41.15 | 40.72% | |
| BUY | $39.5B | -11.74% | 46.93 | 27.93% | |
| BUY | $36.5B | NA | 16.56 | 10.95% |
The Sophia Genetics Sa stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Sophia Genetics Sa investment value today
Current value as on today
₹1,52,072
Returns
₹52,072
(+52.07%)
Returns from Sophia Genetics Sa Stock
₹45,954 (+45.95%)
Dollar Returns*
₹6,118 (+6.12%)
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Sophia Genetics Sa. Average target price of $7.33
Get share price movements and forecasts by analysts on Sophia Genetics Sa.
What analysts predicted
31.11%UPSIDE
Target Price
$7.33
Current Price
$5.05
Analyzed by
10 Analysts
Target
$7.33
Sophia Genetics Sa target price $7.33, a slight upside of 31.11% compared to current price of $5.05. According to 10 analysts rating.
Search interest for Sophia Genetics Sa Stock has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 04 November
Wed, 00:19 AM
-SOPHiA GENETICS launches SOPHiA DDM Digital Twins, an AI-powered tool for cancer treatment simulations.
Wed, 06:34 AM
-SOPHiA GENETICS reports 23% revenue growth in Q3, raises 2025 revenue guidance to $75-$77 million.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 7 quarters, 15.77M → 19.46M (in $), with an average increase of 3.4% per quarter
Price Rise
![]()
In the last 3 months, SOPH stock has moved up by 44.3%
Best in 1 Year
![]()
In the last 1 year, SOPH has outperformed top 5 stocks with highest market-cap in its industry
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -22.41M → -20.02M (in $), with an average increase of 12.0% per quarter
Best in 3 Years
![]()
In the last 3 years, SOPH has outperformed top 5 stocks with highest market-cap in its industry
| Organisation | Sophia Genetics Sa |
| Headquarters | La PiEce 12, Rolle, Switzerland, 1180 |
| Industry | Technology |
| CEO | Dr. Jurgi Camblong M.B.A., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Kellen Sanger | Head of Strategy and Investor Relations |
Ms. Manuela Da Silva Valente B.A. | Executive VP & Chief People Officer |
Dr. Philippe Menu M.B.A., M.D., Ph.D. | Executive VP, Chief Medical Officer & Chief Product Officer |
Dr. Jurgi Camblong M.B.A., Ph.D. | Co-Founder, CEO & Director |
Mr. Ross Jordan Muken B.Sc. | President |
Mr. George A. Cardoza M.B.A. | Executive VP & CFO |
Mr. Abhimanyu Verma | Senior VP & CTO |
Dr. Zhenyu Xu Ph.D. | Executive VP & Chief Scientific Officer |
Mr. Daan van Well L.L.M., M.B.A. | Executive VP, Chief Legal & Regulatory Officer |
Mr. Kevin Puylaert | VP & MD of EMEA |
Sophia Genetics Sa share price today is $5.05 as on . Sophia Genetics Sa share today touched a day high of $5.15 and a low of $4.79.
Sophia Genetics Sa share touched a 52 week high of $5.3 on and a 52 week low of $2.58 on . Sophia Genetics Sa stock price today i.e. is trending at $5.05,which is 4.72% down from its 52 week high and 95.74% up from its 52 week low.
Sophia Genetics Sa market capitalisation is $0.00T as on .
Indian investors can start investing in Sophia Genetics Sa (SOPH) shares with as little as ₹89.935 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹899.35 in Sophia Genetics Sa stock (as per the Rupee-Dollar exchange rate as on ).
Based on Sophia Genetics Sa share’s latest price of $5.05 as on December 3, 2025 at 1:45 am IST, you will get 1.9802 shares of Sophia Genetics Sa. Learn more about
fractional shares .